Adalimumab (HUMIRA 40mg for SC Injection) Inject SC 160mg on Day 1, then inject SC 80 mg on Day 15, and inject SC 40 mg every other week, beginning on Day 29.

2 trials

Sponsors

Kenji Watanabe, Nagoya University Gradeate School of Medicine Department of Gastroenterology

Conditions

Crohn&#39

Phase 2

Phase ll Study of Postoperative Adalimumab Maintenance Therapy for Crohn's Disease Recurrence

Active, not recruitingJPRN-UMIN000007514

Nagoya University Gradeate School of Medicine Department of GastroenterologyCrohn&#39

Start: 2012-01-01Target: 25Updated: 2026-06-29

Unknown Phase

The Study for Efficacy and Safety of Adalimumab for Crohn's Disease with Loss of Response to Infliximab

Active, not recruitingJPRN-UMIN000005761

Kenji WatanabeCrohn&#39

Start: 2010-10-27Target: 50Updated: 2026-06-29

Related Papers

Postoperative adalimumab maintenance therapy for Japanese patients with Crohn's disease: a single-center, single-arm phase II trial (CCOG-1107 study).

2018-02-2312 citations